Literature DB >> 33652667

Systematic Identification of MACC1-Driven Metabolic Networks in Colorectal Cancer.

Jan Lisec1,2,3, Dennis Kobelt2,4, Wolfgang Walther2,4, Margarita Mokrizkij2,4, Carsten Grötzinger2,5, Carsten Jaeger1, Katharina Baum6,7, Mareike Simon7, Jana Wolf7, Nicola Beindorff8, Winfried Brenner2,8,9, Ulrike Stein2,4.   

Abstract

MACC1 is a prognostic and predictive metastasis biomarker for more than 20 solid cancer entities. However, its role in cancer metabolism is not sufficiently explored. Here, we report on how MACC1 impacts the use of glucose, glutamine, lactate, pyruvate and fatty acids and show the comprehensive analysis of MACC1-driven metabolic networks. We analyzed concentration-dependent changes in nutrient use, nutrient depletion, metabolic tracing employing 13C-labeled substrates, and in vivo studies. We found that MACC1 permits numerous effects on cancer metabolism. Most of those effects increased nutrient uptake. Furthermore, MACC1 alters metabolic pathways by affecting metabolite production or turnover from metabolic substrates. MACC1 supports use of glucose, glutamine and pyruvate via their increased depletion or altered distribution within metabolic pathways. In summary, we demonstrate that MACC1 is an important regulator of metabolism in cancer cells.

Entities:  

Keywords:  MACC1; cancer metabolism; colorectal cancer; metabolic networks; metabolic profiling

Year:  2021        PMID: 33652667     DOI: 10.3390/cancers13050978

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  2 in total

1.  A Flexible Tool to Correct Superimposed Mass Isotopologue Distributions in GC-APCI-MS Flux Experiments.

Authors:  Jennifer Langenhan; Carsten Jaeger; Katharina Baum; Mareike Simon; Jan Lisec
Journal:  Metabolites       Date:  2022-04-29

2.  Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association.

Authors:  Tobias Pischon; Ulrike Stein; Ina Bähr; Lina Jaeschke; Katharina Nimptsch; Jürgen Janke; Pia Herrmann; Dennis Kobelt; Heike Kielstein
Journal:  Int J Oncol       Date:  2022-01-11       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.